- Fund Type: SICAV
- Objective: Growth
- Asset Class: Equity
- Geographic Focus: Spain
Alcor Cartera SICAV SA
+ Add to WatchlistS0094:SM
7.81 EUR 0.000.00%As of 10:00:30 ET on 05/17/2013.
Snapshot for Alcor Cartera SICAV SA (S0094)
| Year To Date: | +3.71% | 3-Month: | +2.53% | 3-Year: | +3.12% | 52-Week Range: | 7.10 - 7.83 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +2.10% | 1-Year: | +9.34% | 5-Year: | +1.20% | Beta vs IBEX: | 0.43 |
Fund Profile & Information for S0094
Alcor Cartera SICAV SA is an open-end investment company incorporated in Spain. The investment company's objective is capital growth. It primarily invests in equity securities.
| Inception Date: | 07-20-2006 | Telephone: | 34-93-404-7700 |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.lacaixa.es | ||
Fundamentals for S0094
| NAV | (on 2013-05-17) 7.81 |
|---|---|
| Assets (M) | (on 2013-04-03) 3.95 |
| Fund Leveraged | N |
| Minimum Investment | - |
| Minimum Subsequent Investment | - |
Dividends for S0094
No dividends reported
Fees & Expenses for S0094
| Front Load | - |
|---|---|
| Back Load | - |
| Current Mgmt Fee | 0.60 |
| Redemption Fee | - |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for S0094
Filing Date: 05/31/2012| Name | Position | Value | % of Total |
|---|---|---|---|
| PIMCO Funds Global Investors S | 14,758 | 174,730 | 3.806% |
| BNY Mellon Global Funds plc - | 140,775 | 168,874 | 3.679% |
| CABKSM 3 ¾ 11/05/13 | 150 | 147,704 | 3.218% |
| BKTSM 4 ⅛ 03/22/17 | 150 | 142,489 | 3.104% |
| DT 5 ⅞ 09/10/14 | 100 | 112,720 | 2.456% |
| JPM 6 ⅛ 04/01/14 | 100 | 110,460 | 2.406% |
| MCFP 4 ⅜ 05/12/14 | 100 | 109,548 | 2.386% |
| GE 4 ¾ 07/30/14 | 100 | 109,489 | 2.385% |
| EDF 5 ⅝ 01/23/13 | 100 | 109,472 | 2.385% |
| REPSM 4 ⅝ 10/08/14 | 105 | 108,577 | 2.365% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page